Chimeric antigen receptor T-cell therapy and fludarabine precision dosing imperatives
Standard
Chimeric antigen receptor T-cell therapy and fludarabine precision dosing imperatives. / Wicha, Sebastian; Wansing, Eva-Maria A; Dadkhah, Adrin; Ayuk, Francis Ayuketang; Kröger, Nicolaus; Langebrake, Claudia.
in: BLOOD ADV, Jahrgang 8, Nr. 3, 13.02.2024, S. 797-798.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Kommentar › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Chimeric antigen receptor T-cell therapy and fludarabine precision dosing imperatives
AU - Wicha, Sebastian
AU - Wansing, Eva-Maria A
AU - Dadkhah, Adrin
AU - Ayuk, Francis Ayuketang
AU - Kröger, Nicolaus
AU - Langebrake, Claudia
N1 - Commentary
PY - 2024/2/13
Y1 - 2024/2/13
U2 - 10.1182/bloodadvances.2023012068
DO - 10.1182/bloodadvances.2023012068
M3 - Comment/debate
C2 - 38191740
VL - 8
SP - 797
EP - 798
JO - BLOOD ADV
JF - BLOOD ADV
SN - 2473-9529
IS - 3
ER -